GlassScriptPhysician profile
Michael J Pelekanos
NPI 1013905884
$10,363.84
in general payments reported to CMS, 2019-2025
28 companies · $563 in 2025
The $563 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $485 · 2021: $3,687 · 2022: $4,302 · 2023: $407 · 2024: $246 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lina Medical USA INC | $3,400.00 | 2022 | |
| Coopersurgical, INC. | $2,474.35 | 2019-2025 | Ally II Ups, Advincula Delineator Uterine Manipulator, Endosee |
| Axonics, INC. | $1,017.77 | 2021-2024 | Axonics, Bulkamid |
| Gyrus Acmi, INC. | $660.00 | 2021 | |
| Abbvie INC. | $502.54 | 2019-2025 | |
| Coloplast Corp | $482.51 | 2021-2025 | Altis |
| Olympus Corporation of The Americas | $330.00 | 2021 | |
| Medtronic, INC. | $213.96 | 2022 | |
| Caldera Medical, INC | $186.91 | 2021-2022 | |
| Olympus America INC. | $134.08 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $130.97 | 2023-2025 | |
| Boston Scientific Corporation | $122.34 | 2024-2025 | Axonics |
| Acessa Health INC. | $86.43 | 2020 | |
| Pfizer INC. | $80.50 | 2021-2023 | |
| Minerva Surgical, INC | $78.76 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $73.34 | 2019-2020 | |
| Exact Sciences Corporation | $54.92 | 2025 | The Cologuard Plus Collection Kit |
| Cumberland Pharmaceuticals, INC. | $48.05 | 2024-2025 | Caldolor |
| Millicent US INC | $47.23 | 2025 | Intrarosa |
| Organon LLC | $44.58 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $39.78 | 2019-2022 | |
| Cook Medical LLC | $28.06 | 2020 | |
| Amag Pharmaceuticals, INC. | $27.79 | 2019-2020 | |
| Astellas Pharma US INC | $25.00 | 2024 | Veozah |
| Becton, Dickinson and Company | $21.28 | 2024 | Arista Ah Flexitip |
| Mylan Pharmaceuticals INC. | $19.17 | 2021 | |
| Exeltis, USA INC. | $17.32 | 2022 | |
| Ethicon US, LLC | $16.20 | 2025 | Enseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pelekanos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.